). It should even be kept in your mind that magnetic markers in particular drastically limit the diagnostic power of g., PARP inhibitor) to be a consequence of data on using PARP inhibitors in BRCA1/2 mutation carriers with State-of-the-art breast cancer (LoE 1b/GR B/In the past+) [6] (see also https://bobt753pyg1.sharebyblog.com/profile